Live tape
Top 8, mentions 7d13,810NVDA3,450 mentions▲ +0.04GOOGL2,420 mentions▲ +0.04AMD1,805 mentions▲ +0.08SPY1,573 mentions▲ +0.06QQQ1,572 mentions▲ +0.05SPCX1,069 mentions▲ +0.05TSLA986 mentions▲ +0.05AAPL935 mentions▲ +0.05

Equity · Healthcare

GMED

NYSE

Globus Medical (GMED)

76 USD −0.90% vs prior close
Globus Medical, Inc. price graph

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for GMED to draw a line in its place.

Track this symbol on TradingView
Market cap
10.2B USD
P/E (TTM)
18.8
Revenue, year to Dec 2025
2.9B USD
EPS, diluted, year to Dec 2025
3.92 USD
52-week range
57.51 USD – 99 USD
Avg volume
75.6K

as of Oct 19, 2026

Have Globus Medical (GMED) insiders bought or sold shares recently?

GMED has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 4 November 2026.

Form 4

Have Globus Medical (GMED) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
04 Nov 2026RHOADS ANN DDirectorSell5,000425K USD
15 Sep 2026TOBIN JAMES RDirectorSell30,0002.2M USD
18 Aug 2026ZARRILLI STEPHEN TDirectorSell25,0002.2M USD
05 Jun 2026Davidar David DDirectorSell25,0002.0M USD
25 Feb 2026Huller KellyEVP, GC, Corporate SecretarySell20,0001.9M USD
12 Feb 2026Huller KellyEVP, GC, Corporate SecretarySell10,000877K USD
08 Jan 2026Kline KyleSenior Vice President, CFOSell3,594363K USD
08 Jan 2026Norwalk Leslie VDirectorSell2,000202K USD
12 Dec 2025Norwalk Leslie VSell4,000355K USD
01 Dec 2025Kline KyleSenior Vice President, CFOSell18,5421.7M USD
25 Nov 2025Huller KellySVP, GC, Corporate SecretarySell7,500675K USD
12 Nov 2025Davidar David DSell25,0002.2M USD
Sold15 open-market sales210,636$17.96M

Showing the 12 most recent of 15 open-market trades in this window. The figures above count all of them.

13 other filings: grants, exercises, tax withholding and transfers, not trades
Have Globus Medical (GMED) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
15 Sep 2026TOBIN JAMES RDirectorOption exercise30,0001.8M USD
18 Aug 2026ZARRILLI STEPHEN TDirectorOption exercise25,0001.3M USD
27 Jul 2026Davidar David DDirectorGift2,500
05 Jun 2026Davidar David DDirectorOption exercise25,000657K USD
04 Jun 2026RHOADS ANN DDirectorOption exercise25,000657K USD
25 Feb 2026Huller KellyEVP, GC, Corporate SecretaryOption exercise20,000872K USD
12 Feb 2026Huller KellyEVP, GC, Corporate SecretaryOption exercise10,000456K USD
08 Jan 2026Kline KyleSenior Vice President, CFOOption exercise3,594186K USD
08 Dec 2025Paul David CExecutive ChairmanOption exercise34,375877K USD
01 Dec 2025Kline KyleSenior Vice President, CFOOption exercise13,542788K USD
25 Nov 2025Huller KellySVP, GC, Corporate SecretaryOption exercise7,500195K USD
12 Nov 2025Davidar David DOption exercise25,000638K USD

Showing the 12 most recent of 13 compensation filings in this window. The figures above count all of them.

Which funds hold Globus Medical (GMED)?

8 of the 45 institutional funds we track reported a Globus Medical position for the quarter ended 30 Jun 2026 — a combined 78.6M USD; the latest of those filings landed 02 Sep 2026.

Form 13F

Which funds hold Globus Medical (GMED)?
FundPositionSharesValueShares q/q
Bridgewater AssociatesHeld (±25%)351,97427.8M USD+6.5%
Renaissance TechnologiesNew position196,91815.6M USD
Marshall WaceTrimmed188,54114.9M USD−66.5%
GAMCO InvestorsHeld (±25%)129,21710.2M USD−0.0%
Man GroupAdded55,3204.4M USD+33.4%
AQR Capital ManagementTrimmed36,5342.9M USD−95.7%
Millennium ManagementTrimmed28,8352.3M USD−98.2%
D. E. Shaw & Co.Trimmed8,300656K USD−70.7%
Balyasny Asset ManagementExited
Citadel AdvisorsExited

Have members of Congress traded Globus Medical (GMED)?

The most recent congressional trade disclosed in Globus Medical is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 03 Sep 2026.

STOCK Act disclosures

Have members of Congress traded Globus Medical (GMED)?
TradedMemberTypeAmountFiled after
03 Sep 2026Gilbert Ray Cisneros, Jr.house · Democrat–CAPurchase1K USD–15K USD39 days
19 Aug 2026Gilbert Ray Cisneros, Jr.house · Democrat–CAPurchase15K USD–50K USD22 days
10 Jul 2025Lisa C. McClainhouse · Republican–MISale1K USD–15K USD34 days
24 Jun 2025Lisa C. McClainhouse · Republican–MISale1K USD–15K USD50 days
17 Jun 2025Lisa C. McClainhouse · Republican–MIPurchase1K USD–15K USD57 days
09 Apr 2025Josh Gottheimerhouse · Democrat–NJSale1K USD–15K USD35 days
03 Apr 2023Josh Gottheimerhouse · Democrat–NJPurchase1K USD–15K USD46 days
08 Feb 2023Josh Gottheimerhouse · Democrat–NJSale1K USD–15K USD37 days

What has been filed or recorded for Globus Medical (GMED)?

The filings we hold for Globus Medical, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Sep 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Globus Medical (GMED)?
And
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS 1.04 USDRevenue $764M
30 Sep 2026FinancialsTotal assets5.5B USDat period end
30 Sep 2026FinancialsTotal equity4.8B USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS 1.10 USDRevenue $790M
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS 0.90 USDRevenue $760M
31 Dec 2025Annual reportFY 2025 reportedEPS 3.92 USDRevenue $2.94B
31 Dec 2025FinancialsRevenue2.9B USDfiscal year
31 Dec 2025FinancialsNet income537.9M USDfiscal year
31 Dec 2025FinancialsDiluted EPS3.92 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS 0.88 USDRevenue $769M
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS 1.49 USDRevenue $745M
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS 0.54 USDRevenue $598M
31 Dec 2024Annual reportFY 2024 reportedEPS 0.75 USDRevenue $2.52B

Globus Medical (GMED): frequently asked questions

From live data
10.2B

What is Globus Medical’s market cap?

Globus Medical is worth 10.2B USD by market value as of 19 Oct 2026, which is the share price times the shares on issue from its SEC filings.

18.8

What is Globus Medical’s P/E ratio?

Globus Medical has a price-to-earnings ratio of 18.8, as of 19 Oct 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.

2.9B

What is Globus Medical’s revenue?

Globus Medical reported revenue of 2.9B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Globus Medical insiders bought or sold shares recently?

No Globus Medical insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 4 Nov 2026 (SEC Form 4). See Insiders

8 of 45

Which funds own Globus Medical?

8 of the 45 funds we track reported a Globus Medical position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Bridgewater Associates, Renaissance Technologies and Marshall Wace. See Funds

12 trades

Have members of Congress traded Globus Medical?

Yes. 12 trades in Globus Medical appear in the congressional disclosures we hold; the latest is a purchase by Gilbert Ray Cisneros, Jr. (House, CA) dated 3 Sep 2026, filed 12 Oct 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress

1.04

When did Globus Medical last report earnings?

Globus Medical last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 1.04 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. House disclosuresU.S. House of Representatives financial disclosures
  6. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  7. SEC EDGARreported earnings figures and scheduled report dates
  8. SEC EDGARValuation computed from SEC EDGAR filings
  9. Wikipediatext of the lead paragraph, licensed CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) — https://en.wikipedia.org/wiki/Globus_Medical